| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2025-11-19 |
$4.97 |
0.0% |
53,900
|
$267,915 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2025-08-21 |
$6.60 |
0.0% |
58,664
|
$387,100 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2025-06-13 |
$7.64 |
0.0% |
10,000
|
$76,392 |
| Whitmore Bradford T |
Non-Executive |
SOLESENCE, INC. (SLSN)
|
2025-05-29 |
$4.20 |
0.0% |
6,689,000
|
$28,093,800 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2025-05-23 |
$5.41 |
0.0% |
11,980
|
$64,778 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2025-05-15 |
$5.47 |
0.0% |
27,160
|
$148,475 |
| Whitmore Bradford T |
Non-Executive |
NANOPHASE TECHNOLOGIES Corp (NANX)
|
2024-02-08 |
$0.40 |
280.0% |
3,824,864
|
$1,529,946 |
| Whitmore Bradford T |
Non-Executive |
Clearside Biomedical, Inc. (CLSD)
|
2024-02-07 |
$20.25 |
-95.4% |
29,630
|
$599,999 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2023-12-08 |
$6.99 |
37.4% |
15,877
|
$110,943 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2023-11-29 |
$7.20 |
33.4% |
25,100
|
$180,651 |
| Whitmore Bradford T |
Non-Executive |
Clearside Biomedical, Inc. (CLSD)
|
2023-11-01 |
$11.03 |
-91.6% |
9,052
|
$99,849 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2023-11-01 |
$7.14 |
34.5% |
13,871
|
$98,991 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2023-09-15 |
$10.15 |
-5.4% |
11,000
|
$111,613 |
| Whitmore Bradford T |
Non-Executive |
NANOPHASE TECHNOLOGIES Corp (NANX)
|
2023-08-23 |
$0.92 |
65.4% |
85,847
|
$78,899 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2023-06-14 |
$4.94 |
94.4% |
80,598
|
$398,096 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2023-06-02 |
$4.40 |
118.2% |
5,964
|
$26,242 |
| Whitmore Bradford T |
Non-Executive |
NANOPHASE TECHNOLOGIES Corp (NANX)
|
2023-06-01 |
$1.18 |
29.0% |
16,400
|
$19,328 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2023-06-01 |
$4.31 |
122.7% |
33,963
|
$146,392 |
| Whitmore Bradford T |
Non-Executive |
NANOPHASE TECHNOLOGIES Corp (NANX)
|
2023-05-19 |
$0.84 |
80.9% |
66,890
|
$56,199 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2023-05-11 |
$4.06 |
136.6% |
28,788
|
$116,783 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2023-03-13 |
$4.06 |
136.3% |
30,000
|
$121,893 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2022-12-16 |
$4.00 |
140.3% |
38,032
|
$151,962 |
| Whitmore Bradford T |
Non-Executive |
NANOPHASE TECHNOLOGIES Corp (NANX)
|
2022-12-15 |
$1.10 |
38.2% |
300,488
|
$330,597 |
| Whitmore Bradford T |
Non-Executive |
NANOPHASE TECHNOLOGIES Corp (NANX)
|
2022-12-08 |
$1.19 |
27.7% |
178,768
|
$212,867 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2022-12-08 |
$4.03 |
138.3% |
69,196
|
$278,729 |
| Whitmore Bradford T |
Non-Executive |
NANOPHASE TECHNOLOGIES Corp (NANX)
|
2022-11-18 |
$1.39 |
9.1% |
133,185
|
$185,498 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2022-08-18 |
$4.62 |
107.7% |
34,100
|
$157,628 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2022-08-04 |
$4.67 |
105.4% |
100,000
|
$467,486 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2022-06-08 |
$5.10 |
88.1% |
42,970
|
$219,252 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2022-02-28 |
$4.45 |
115.9% |
55,030
|
$244,690 |
| Whitmore Bradford T |
Non-Executive |
NANOPHASE TECHNOLOGIES Corp (NANX)
|
2021-12-21 |
$4.19 |
-63.7% |
7,731,573
|
$32,361,272 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2021-12-17 |
$5.57 |
72.3% |
53,251
|
$296,624 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2021-08-04 |
$7.91 |
21.4% |
25,200
|
$199,271 |
| Whitmore Bradford T |
Non-Executive |
Clearside Biomedical, Inc. (CLSD)
|
2021-01-06 |
$42.77 |
-97.8% |
23,383
|
$999,988 |
| Whitmore Bradford T |
Non-Executive |
Clearside Biomedical, Inc. (CLSD)
|
2020-12-24 |
$29.27 |
-96.8% |
3,413
|
$99,897 |
| Whitmore Bradford T |
Non-Executive |
Clearside Biomedical, Inc. (CLSD)
|
2020-12-02 |
$29.23 |
-96.8% |
3,593
|
$105,051 |
| Whitmore Bradford T |
Non-Executive |
Clearside Biomedical, Inc. (CLSD)
|
2020-11-24 |
$24.69 |
-96.2% |
4,133
|
$102,046 |
| Whitmore Bradford T |
Non-Executive |
Clearside Biomedical, Inc. (CLSD)
|
2020-11-16 |
$25.39 |
-96.3% |
4,133
|
$104,929 |
| Whitmore Bradford T |
Non-Executive |
Clearside Biomedical, Inc. (CLSD)
|
2020-08-13 |
$24.50 |
-96.2% |
23,333
|
$571,680 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2020-05-14 |
$7.43 |
29.2% |
5,000
|
$37,146 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2020-05-11 |
$8.15 |
17.9% |
8,810
|
$71,764 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2020-05-06 |
$8.01 |
19.8% |
11,190
|
$89,649 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2020-03-17 |
$5.50 |
74.5% |
50,000
|
$275,060 |
| Whitmore Bradford T |
Non-Executive Director |
ULTRALIFE CORP (ULBI)
|
2020-02-19 |
$7.24 |
32.6% |
100,000
|
$723,721 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
-21.2% |
$-15,091,263 |
$71,021,093 |